John Huddlestone

1.3k total citations
17 papers, 892 citations indexed

About

John Huddlestone is a scholar working on Immunology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, John Huddlestone has authored 17 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in John Huddlestone's work include Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). John Huddlestone is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). John Huddlestone collaborates with scholars based in United States and Canada. John Huddlestone's co-authors include Michael B. A. Oldstone, Thomas C. Merigan, T. C. Merigan, Robert I. Fox, L F Thompson, Edward Lewin, Bengt Härfast, Soldano Ferrone, M B Oldstone and Francesco Indiveri and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

John Huddlestone

17 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Huddlestone United States 11 380 248 182 131 125 17 892
A. D. Crockard United Kingdom 15 422 1.1× 143 0.6× 128 0.7× 234 1.8× 43 0.3× 48 927
Laurent Delpy France 20 622 1.6× 101 0.4× 154 0.8× 304 2.3× 86 0.7× 37 1.2k
Simone Vogel Germany 13 377 1.0× 54 0.2× 150 0.8× 233 1.8× 48 0.4× 24 848
Judith Fraussen Belgium 17 554 1.5× 355 1.4× 115 0.6× 204 1.6× 80 0.6× 28 1.1k
M Feldmann United Kingdom 14 203 0.5× 94 0.4× 94 0.5× 145 1.1× 61 0.5× 35 662
Nobuo Koike United States 13 310 0.8× 190 0.8× 161 0.9× 144 1.1× 21 0.2× 23 827
Domenico Adorno Italy 20 498 1.3× 118 0.5× 327 1.8× 162 1.2× 47 0.4× 48 1.1k
Rika Ouchida Japan 20 411 1.1× 95 0.4× 187 1.0× 585 4.5× 110 0.9× 31 1.1k
Judith F. Ashouri United States 13 461 1.2× 132 0.5× 187 1.0× 207 1.6× 31 0.2× 18 941
Chengbo Fang China 7 369 1.0× 97 0.4× 69 0.4× 247 1.9× 38 0.3× 9 862

Countries citing papers authored by John Huddlestone

Since Specialization
Citations

This map shows the geographic impact of John Huddlestone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Huddlestone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Huddlestone more than expected).

Fields of papers citing papers by John Huddlestone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Huddlestone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Huddlestone. The network helps show where John Huddlestone may publish in the future.

Co-authorship network of co-authors of John Huddlestone

This figure shows the co-authorship network connecting the top 25 collaborators of John Huddlestone. A scholar is included among the top collaborators of John Huddlestone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Huddlestone. John Huddlestone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lublin, Fred, James D. Bowen, John Huddlestone, et al.. (2014). Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study. Multiple Sclerosis and Related Disorders. 3(6). 696–704. 101 indexed citations
2.
3.
O’Mara, Edward, Claudia Kasserra, John Huddlestone, et al.. (2010). Effect of Vicriviroc on the QT/Corrected QT Interval and Central Nervous System in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 54(6). 2448–2454. 9 indexed citations
4.
Kudrow, David, Lynn R. Webster, John Huddlestone, et al.. (2008). (273) Clinical trial results: A randomized, double-blind, placebo controlled, trial of three-day bupivacaine transdermal patch (ELADUR) in patients with post-herpetic neuralgia. Journal of Pain. 9(4). 44–44. 2 indexed citations
5.
Knobler, Robert L., Hillel Panitch, S. L. Braheny, et al.. (1984). Clinical Trial of Natural Alpha Interferon in Multiple Sclerosisa. Annals of the New York Academy of Sciences. 436(1). 382–388. 12 indexed citations
6.
Knobler, Robert L., H. S. Panitch, S. L. Braheny, et al.. (1984). Systemic alpha‐interferon therapy of multiple sclerosis. Neurology. 34(10). 1273–1273. 99 indexed citations
7.
Huddlestone, John & M B Oldstone. (1982). Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack.. The Journal of Immunology. 129(3). 915–917. 24 indexed citations
8.
Härfast, Bengt, John Huddlestone, Paolo Casali, T. C. Merigan, & M B Oldstone. (1981). Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.. The Journal of Immunology. 127(5). 2146–2150. 85 indexed citations
9.
Fox, Robert I., L F Thompson, & John Huddlestone. (1981). T gamma cells express T lymphocyte-associated antigens.. The Journal of Immunology. 126(5). 2062–2063. 67 indexed citations
10.
Härfast, Bengt, John Huddlestone, S. L. Braheny, Marjorie E. Seybold, & Michael B. A. Oldstone. (1981). Myasthenia gravis: In vitro immunoglobulin production with pokeweed mitogen challenge and B- and T-lymphocyte competence. Clinical Immunology and Immunopathology. 20(3). 336–345. 7 indexed citations
11.
Indiveri, Francesco, John Huddlestone, Michele Pellegrino, & Soldano Ferrone. (1980). Isolation of human T lymphocytes: Comparison between nylon wool filtration and rosetting with neuraminidase (VCN) and 2-aminoethylisothiouronium bromide (AET)-treated sheep red blood cells (SRBC). Journal of Immunological Methods. 34(2). 107–115. 66 indexed citations
12.
Huddlestone, John, Peter W. Lampert, & Michael B. A. Oldstone. (1980). Virus-lymphocyte interactions: Infection of TG and TM subsets by measles virus. Clinical Immunology and Immunopathology. 15(3). 502–509. 29 indexed citations
13.
Huddlestone, John, Thomas C. Merigan, & Michael B. A. Oldstone. (1979). Induction and kinetics of natural killer cells in humans following interferon therapy. Nature. 282(5737). 417–419. 120 indexed citations
14.
Huddlestone, John & Michael B. A. Oldstone. (1979). Lymphocyte-mediated cytotoxicity to measles virus in patients with multiple sclerosis. Clinical Immunology and Immunopathology. 13(4). 444–451. 4 indexed citations
15.
Huddlestone, John & Michael B. A. Oldstone. (1979). T Suppressor (TG) Lymphocytes Fluctuate in Parallel with Changes in the Clinical Course of Patients with Multiple Sclerosis. The Journal of Immunology. 123(4). 1615–1618. 163 indexed citations
16.
Roberts, Catherine C., et al.. (1978). The role of anti-acetylcholine receptor antibody in neonatal myasthenia gravis.. PubMed. 43(2-4). 66–9. 5 indexed citations
17.
Huddlestone, John, et al.. (1976). A FATAL ENCEPHALOPATHY IN CHRONIC HÆMODIALYSIS PATIENTS. The Lancet. 307(7963). 764–768. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. D. Crockard Breakdown of academic impact, for papers by Laurent Delpy Breakdown of academic impact, for papers by Simone Vogel Breakdown of academic impact, for papers by Judith Fraussen Breakdown of academic impact, for papers by M Feldmann Breakdown of academic impact, for papers by Nobuo Koike Breakdown of academic impact, for papers by Domenico Adorno Breakdown of academic impact, for papers by Rika Ouchida Breakdown of academic impact, for papers by Judith F. Ashouri Breakdown of academic impact, for papers by Chengbo Fang
Rankless by CCL
2026